Hypoxia imaging with [F-18] FMISO-PET in head and neck cancer: potential for guiding intensity modulated radiation therapy in overcoming hypoxia-induced treatment resistance.

[1]  Joseph O Deasy,et al.  Radiotherapy dose-volume effects on salivary gland function. , 2010, International journal of radiation oncology, biology, physics.

[2]  T. Schultheiss,et al.  Radiation dose-volume effects in the spinal cord. , 2010, International journal of radiation oncology, biology, physics.

[3]  Sadek Nehmeh,et al.  Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study. , 2008, International journal of radiation oncology, biology, physics.

[4]  Daniela Thorwarth,et al.  Hypoxia dose painting by numbers: a planning study. , 2007, International journal of radiation oncology, biology, physics.

[5]  Nancy Lee,et al.  Intensity‐modulated radiation therapy in head and neck cancers: An update , 2007, Head & neck.

[6]  D. Olsen,et al.  Optimization of tumour control probability in hypoxic tumours by radiation dose redistribution: a modelling study , 2007, Physics in medicine and biology.

[7]  M. Phillips,et al.  2614 : Parametric Images Derived From Kinetic Modeling of Dynamic [F-18] FMISO PET - Evaluating the Feasibility of IMRT Based Dose Escalation to Hypoxic Sub-Volumes , 2006 .

[8]  David L. Schwartz,et al.  Tumor Hypoxia Imaging with [F-18] Fluoromisonidazole Positron Emission Tomography in Head and Neck Cancer , 2006, Clinical Cancer Research.

[9]  Brian O'Sullivan,et al.  Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis , 2006, The Lancet.

[10]  David J. Carlson,et al.  Effects of oxygen on intrinsic radiation sensitivity: A test of the relationship between aerobic and hypoxic linear-quadratic (LQ) model parametersa). , 2006, Medical physics.

[11]  X. Li,et al.  Dose escalation to combat hypoxia in prostate cancer: a radiobiological study on clinical data. , 2006, The British journal of radiology.

[12]  D. Mankoff,et al.  Hypoxia imaging-directed radiation treatment planning , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[13]  Performance evaluation of an integrated PET/CT scanner: Discovery STE , 2006 .

[14]  R. Fisher,et al.  Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Vladimir A Semenenko,et al.  Effects of oxygen on intrinsic radiation sensitivity: A test of the relationship between aerobic and hypoxic linear-quadratic (LQ) model parameters. , 2006, Medical physics.

[16]  K. Krohn,et al.  A new synthesis of the labeling precursor for [18F]- fluoromisonidazole , 2005 .

[17]  Kenneth A Krohn,et al.  Imaging hypoxia and angiogenesis in tumors. , 2005, Radiologic clinics of North America.

[18]  K. Ang,et al.  Altered radiation therapy fractionation, chemoradiation, and patient selection for the treatment of head and neck squamous carcinoma. , 2004, Seminars in radiation oncology.

[19]  Anders Brahme,et al.  Recent advances in light ion radiation therapy. , 2004, International Journal of Radiation Oncology, Biology, Physics.

[20]  F. O’Sullivan,et al.  Hypoxia and Glucose Metabolism in Malignant Tumors: Evaluation by [F]Fluoromisonidazole and [F]Fluorodeoxyglucose Positron Emission Tomography Imaging , 2004 .

[21]  Alessandra Bolsi,et al.  Comparative dosimetric evaluation of the simultaneous integrated boost with photon intensity modulation in head and neck cancer patients. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  Cai Grau,et al.  Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial , 2003, The Lancet.

[23]  C. Koch,et al.  Prognostic significance of tumor oxygenation in humans. , 2003, Cancer letters.

[24]  J. Eary,et al.  [18F]FMISO and [18F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[25]  Richard A Popple,et al.  Tumor control probability for selective boosting of hypoxic subvolumes, including the effect of reoxygenation. , 2002, International journal of radiation oncology, biology, physics.

[26]  M. Muzi,et al.  Analyzing the results of 18FMISO PET hypoxia imaging What is the best way to quantify hypoxia , 2002 .

[27]  S Mutic,et al.  A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. , 2001, International journal of radiation oncology, biology, physics.

[28]  J. Brown,et al.  Therapeutic targets in radiotherapy. , 2001, International journal of radiation oncology, biology, physics.

[29]  H. Withers,et al.  Transmutability of dose and time. Commentary on the first report of RTOG 90003 (K. K. FU et al.) , 2000, International journal of radiation oncology, biology, physics.

[30]  D A Low,et al.  Intensity‐modulated radiation therapy in head and neck cancers: The Mallinckrodt experience , 2000, International journal of cancer.

[31]  A. Garden,et al.  A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. , 2000, International journal of radiation oncology, biology, physics.

[32]  D A Bloch,et al.  Tissue oxygen distribution in head and neck cancer patients , 1999, Head & neck.

[33]  D. Low,et al.  Quality assurance of serial tomotherapy for head and neck patient treatments. , 1998, International journal of radiation oncology, biology, physics.

[34]  Paul Kinahan,et al.  Attenuation correction for a combined 3D PET/CT scanner. , 1998, Medical physics.

[35]  M. Dewhirst,et al.  Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. , 1997, International journal of radiation oncology, biology, physics.

[36]  T K Lewellen,et al.  Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients. , 1996, International journal of radiation oncology, biology, physics.

[37]  Christopher U. Jones,et al.  Local control of carcinoma of the tonsil by radiation therapy: an analysis of patterns of fractionation in nine institutions. , 1995, International journal of radiation oncology, biology, physics.

[38]  Thomas K. Lewellen,et al.  Investigation of the count rate performance of General Electric Advance positron emission tomograph , 1995 .

[39]  K L Lindsley,et al.  Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography. , 1995, International journal of radiation oncology, biology, physics.

[40]  C. Stearns,et al.  Investigation of the count rate performance of the General Electric Advance positron emission tomograph , 1994, Proceedings of 1994 IEEE Nuclear Science Symposium - NSS'94.

[41]  T G Turkington,et al.  Performance characteristics of a whole-body PET scanner. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[42]  S Webb,et al.  A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. , 1993, Physics in medicine and biology.

[43]  P Vaupel,et al.  Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[44]  M. Goitein,et al.  Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.

[45]  C. Burman,et al.  Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. , 1989, International journal of radiation oncology, biology, physics.

[46]  J. M. Taylor,et al.  Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation. , 1989, International journal of radiation oncology, biology, physics.

[47]  Michael V. Green,et al.  Post-injection transmission attenuation measurements for PET , 1988 .

[48]  A B Wolbarst,et al.  Optimization of radiation therapy, III: A method of assessing complication probabilities from dose-volume histograms. , 1987, International journal of radiation oncology, biology, physics.

[49]  K. Hamacher,et al.  Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[50]  J. Lyman.  Complication probability as assessed from dose-volume histograms. , 1985, Radiation research. Supplement.